|
|
 |
|
Viewing report
|
|
|
|
The Neuroscience Perspective: Opportunities For Market Entry & Expansion
BioInformatics, LLC, Oct 2005, Pages: 138
Neuroscience is a technique-driven discipline that, at its core, involves the complex interplay of molecules, neurons and processes of the nervous system. Much of what is now known about the mechanisms underlying vision, hearing, learning, breathing, and human behavior was first discovered in the laboratory. Neuroscientists require not only biologicals and instrumentation that are commonplace in the life sciences, but also need access to specialized reagents and equipment because of the nature of their work. Through their research, neuroscientists:
- Describe the brain and how it functions;
- Determine how the nervous system develops, matures and maintains itself;
- Discover how to prevent and/or cure neurological and psychiatric disorders.
Based on a 31-question survey of neuroscientists conducting basic, translational and clinical research, The Neuroscience Perspective: Opportunities for Market Entry & Expansion, provides suppliers with critical information regarding neuroscientists' preferred techniques and instrumentation in four strategic areas: nucleic acids, proteins, cells and imaging. The report offers suppliers a unique look at current and future spending for neuroscience-related technologies and identifies areas where suppliers can enter the neuroscience market based upon the adoption of new research techniques.
Advances in genomic technology and neuroimaging coupled with a wider range of model organisms has made it possible to conduct more complicated experiments to learn how neurons communicate with one another. More than any other life science discipline, neuroscience research requires a multi-level approach involving molecular, cellular, systems, translational, and integrative tools. By using this report to understand the actual needs and preferences of neuroscientists, suppliers will be better able to position their products to this specialized customer segment.
Given the significant impact of nervous system diseases on a nation's public health and economy—nearly one in three Americans will suffer from a nervous system-related disease during his or her lifetime; these diseases account for six out of the ten most common disabilities in the United States1—increased funding for neuroscience research has been a top priority of the National Institutes of Health. In fact, the research budget for the National Institute of Neurological Disorders and Stroke (NINDS) has almost doubled since 1998 from $661 million to $1.3 billion for 20042. In addition to this financial investment, NINDS, like other national centers of excellence, is hoping to spur on discovery in the areas of development, degeneration and plasticity of the nervous system. This report reveals which avenues of exploration will receive more resources in 2006 and thus will be in need of additional support from suppliers.
Report Highlights
The Neuroscience Perspective: Opportunities for Market Entry & Expansion contains over 40 charts and/or tables and more than 15 cross-tabulations for the 31 survey questions (see Page 4). Below is a glimpse of the key findings derived from just a few of the survey questions:
- Almost half of all respondents conduct basic neuroscience research using animal models. Another quarter conduct basic neuroscience research involving the molecular characterization of genes and/or pathways. (Question 2)
- Animal models, molecular and/or cellular approaches, and cell or tissue culture are common general approaches neuroscientists regularly use. (Question 5)
- 42% of respondents expect their operational budgets to increase, while 37% of respondents expect that it will remain the same for 2006. (Question 19)
- 76% of respondents plan to attend 1-2 major scientific meetings in 2006. (Question 21)
- 58% of respondents average 10-20% of their time at conferences visiting the exhibit hall. (Question 22)
Methodology
842 scientists completed a 31-question survey conducted by us (Arlington, Virginia, USA) between September 6 and September 12, 2005.
The electronic questionnaire was fielded to registered members of The Science Advisory Board. sponsors The Science Advisory Board, an online community of more than 26,000 scientists, physicians and healthcare professionals from around the world. The Science Advisory Board is divided into two panels (Research and Clinical) and 'convenes' regularly via the World Wide Web (www.scienceboard.net) to voice their opinions on a wide variety of issues relating to biomedical research and clinical technologies. These experts—representing all aspects of the life sciences and medicine—have agreed to make themselves available to participate in our online research activities. The Science Advisory Board members who participated in this study were drawn from the Board's Research Panel.
The 283 respondents who currently use protein microarrays answered Questions 1 through 4 and Questions 10 through 39. The 410 respondents who plan to use protein microarrays completed Questions 1 through 16
Objectives
The major objectives of this report are as follows:
- Determine what distinguishes neuroscientists from other life scientists in regard to research objectives, techniques and instrumentation.
- Identify which suppliers neuroscientists believe are best qualified to meet their research needs for nucleic acid-, protein-, cell- and imaging-specific reagents and instrumentation.
- Assess the growth potential in neuroscience laboratory budgets for 2006.
- Compare current and future laboratory spending for neuroscience reagents and instrumentation across nucleic acids, proteins, cells and imaging.
- Pinpoint targeted areas for expansion into the neuroscience market based upon the adoption of new research techniques.
- Determine what resources and initiatives attract neuroscientists to vendor exhibit booths.
- Describe the challenges facing the neuroscience field in regard to personnel, training and funding.
- Learn what neuroscience disciplines will lead to research breakthroughs in the next five to ten years and the technologies that will enable them.
- Examine the acceptability of utilizing neuroscience technology for 'real world' applications like enhancement of normal function, court-ordered CNS intervention and 'brain-reading.'
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Short Protocols in Neuroscience: Systems and Behavioral Methods
Short Protocols in Neuroscience: Systems and Behavioral Method
Proximagen Neuroscience Plc
The Social Cognitive Neuroscience of Organizations
Proximagen Neuroscience PLC
Oxford Handbook of Cognitive Neuroscience of Aging: Linking Cognitive and Cerebral Aging
Northstar Neuroscience, Inc. Product Pipeline Analysis
Stem Cell Research Products: Opportunities, Tools & Technologies
Clinical Diabetes Research: Methods and Techniques
The Year in Cognitive Neuroscience 2009
Protein Research: Strategies for Marketing to Chemists and Biologists
Year in Cognitive Neuroscience, 2008
|
|
|
|
